GILDD

Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh · BCBA:GILDD

44.78 USD−0.4200 −0.93%

Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh (BCBA:GILDD) last traded at 44.78 USD, down 0.93% on the day. Over the past year the stock is up 48.23%. Its 52-week range is 29.00 to 45.20. It is in the Health Technology sector (Biotechnology).

Key statistics

Open44.78

Day range44.78 – 44.78

52-week range29.00 – 45.20

Volume6

Average volume (10 days)16

Market cap211.64 B

EPS (TTM)−0.6871

Dividend yield1.04%

Beta (1 year)0.0546

Revenue (TTM)29.35 B

Employees17.00 K

Performance

+6.62%1 week

+17.23%1 month

+37.95%3 months

+26.50%6 months

+49.02%Year to date

+48.23%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Gilead to Present Late-Breaking Clinical Data and Real-World Evidence at HIV GlasgowBusinessWire · 02 Nov 2026
Why Did MO, GILD, XOM Stocks Surge To 52-Week Highs Last Week?Stocktwits · 02 Nov 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Gilead Sciences Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
Gilead Sciences Is Maintained at Overweight by JP MorganDow Jones Newswires · 30 Oct 2026
Gilead Sciences Price Target Raised to $188.00/Share From $165.00 by CitigroupDow Jones Newswires · 30 Oct 2026
Gilead Sciences Is Maintained at Sector Outperform by ScotiabankDow Jones Newswires · 30 Oct 2026
Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor ConferencesBusinessWire · 30 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.